Edesa Biotech Inc (EDSA)

Jul 22, 2025

What analysts say about Edesa Biotech Inc. stockFree Investment Timing Strategies - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Edesa Biotech Inc. Stock Analysis and ForecastConsistent double returns - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Is Edesa Biotech Inc. a good long term investmentOverwhelming profit margins - Autocar Professional

Jul 21, 2025

Jul 20, 2025

What drives Edesa Biotech Inc. stock priceFree Consultation - printweek.in

Jul 20, 2025

Jul 18, 2025

Edesa Biotech Insiders May Regret Not Buying More, Market Cap Hits US$16m - simplywall.st

Jul 18, 2025

Jul 15, 2025

What makes Edesa Biotech Inc. stock price move sharplyElite Stock Shortlist - Newser

Jul 15, 2025

Jul 15, 2025

How Edesa Biotech Inc. stock performs during market volatilityGrowth Stock Monitor - Newser

Jul 15, 2025

Jul 15, 2025

Why Edesa Biotech Inc. stock attracts strong analyst attentionMomentum Swing Watchlist - Newser

Jul 15, 2025

Jul 13, 2025

Edesa Biotech's JUST BREATHE Study Advances ARDS Treatment with Promising Progress - AInvest

Jul 13, 2025

Jul 11, 2025

Edesa Biotech Advances ARDS Treatment with JUST BREATHE Study - TipRanks

Jul 11, 2025

Jul 08, 2025

Edesa Biotech (NASDAQ:EDSA) Shares Down 1% – Here’s Why - Defense World

Jul 08, 2025

Jul 01, 2025

H.C. Wainwright Maintains Edesa Biotech(EDSA.US) With Buy Rating, Maintains Target Price $5 - 富途牛牛

Jul 01, 2025

Jun 11, 2025

Edesa Biotech secures up to C$23 million in funding under the Federal Government’s Strategic Innovation Fund for pivotal clinical study - Fasken

Jun 11, 2025

Jun 11, 2025

Edesa Biotech, Inc. closes US$10 million bought deal offering of common shares - Fasken

Jun 11, 2025

Jun 11, 2025

Edesa Biotech completes US$15 million private placement - Fasken

Jun 11, 2025

Jun 11, 2025

40,944 Shares in Edesa Biotech, Inc. (NASDAQ:EDSA) Bought by Citadel Advisors LLC - Defense World

Jun 11, 2025

May 28, 2025

Edesa Biotech Shareholders Approve Key Proposals at AGM - TipRanks

May 28, 2025

May 23, 2025

Edesa Biotech (EDSA) Receives Buy Rating from Lucid Capital | ED - GuruFocus

May 23, 2025

May 23, 2025

Zacks Small Cap Reduces Earnings Estimates for Edesa Biotech - Defense World

May 23, 2025

May 19, 2025

EDSA: Advancing EB06 for the Treatment of Vitiligo - Research Tree

May 19, 2025

May 19, 2025

EDSA: Advancing EB06 for the Treatment of Vitiligo… - Yahoo Finance

May 19, 2025

May 18, 2025

Positive Signs As Multiple Insiders Buy Edesa Biotech Stock - Yahoo Finance

May 18, 2025

May 15, 2025

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results - GlobeNewswire

May 15, 2025

May 14, 2025

Edesa Biotech Shifts Focus to Vitiligo Treatment in Q2 2025 - TipRanks

May 14, 2025

May 14, 2025

Edesa Biotech Q2 EPS USD -0.3 - marketscreener.com

May 14, 2025

May 14, 2025

Edesa Biotech Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025

May 14, 2025

Edesa Biotech Reports Q2 2025 Financial Results and Advances Vitiligo Drug Development Efforts - Nasdaq

May 14, 2025

May 14, 2025

Edesa Biotech Advances Novel Vitiligo Treatment with $15M Backing from Healthcare Investors - Stock Titan

May 14, 2025

May 13, 2025

Edesa Biotech Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView

May 13, 2025

May 02, 2025

Edesa Biotech (EDSA) to Release Quarterly Earnings on Friday - Defense World

May 02, 2025

Apr 28, 2025

Edesa Biotech to Present at 2024 Bloom Burton Healthcare Investor Conference - TipRanks

Apr 28, 2025

Apr 28, 2025

Edesa Biotech to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference in Toronto - Nasdaq

Apr 28, 2025

Apr 28, 2025

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference - GlobeNewswire

Apr 28, 2025

Apr 28, 2025

Edesa Biotech Showcases Immuno-Inflammatory Pipeline at Bloom Burton Healthcare Conference - Stock Titan

Apr 28, 2025